| 9 | 1/1 | 返回列表 |
| 查看: 3752 | 回復: 8 | ||
| 【懸賞金幣】回答本帖問題,作者叫朕阿瑪將贈送您 50 個金幣 | ||
叫朕阿瑪新蟲 (小有名氣)
|
[求助]
第一次自己寫SCI文章,編輯給了minor revision意見,拿不準該怎么回復 已有2人參與
|
|
|
Reviewer(s)' Comments to Author: Reviewer: 1 Comments to the Author Dear Authors! I liked the article on the disclosure of the pathogenesis of preeclampsia XXXXXXX(我的論文名稱). The article was made at a high scientific level, many research methods were applied, blood plasma and placental tissue were studied. The article is written in understandable language. The advantages of the article include a detailed Discussion. It is important to note the fact, which was also noted in our studies, is an increase in the activity of oncosuppressor genes, against the background of an increase in genes associated with invasion (Nizyaeva NV, Kulikova GV, Nagovitsyna MN, Kan NE, Prozorovskaya KN, Shchegolev AI. Change in OncomicroRNA Expression in the Placenta during Preeclampsia. Bull Exp Biol Med. 2018 Oct; 165 (6): 793-797. Doi: 10.1007 / s10517-018-4267-7. Epub 2018 Oct 23 PMID: 30353329).Sample Text The results are described in detail, the connection with signaling pathways is presented. Some limitation should be considered studies carried out only on cell cultures, and not on experimental models. For some comments, it should be noted that the definition of the molecular profile associated with inflammation in the 2nd trimester of pregnancy is very variable and can increase starting from 12 weeks, reaching a peak at 16-17 weeks, and their decrease by 18-19 weeks. This is the difficulty of studying early terms, especially in cases of clinical trials in humans, when there is always a question with the comparison group.(這是需要我做實驗補充數(shù)據(jù)呢?還是解釋一下就行?我沒有收集12 weeks的樣本,沒辦法補實驗,解釋一下行不行?) I think this article is very interesting and can be published in the journal. Yours sincerely Reviewer: 2 Comments to the Author Preeclampsia is a leading cause of maternal and fetal/neonatal mortality and morbidity worldwide. Investigating the markers of the disease and their possible mechanism of action is important in order to reduce the risk of the disease. There is now an increasing list of markers of preeclampsia are being investigated. XX is one of them. This is an interesting study presenting the mechanisms of involvement of XX in preeclampsia. However, I think presenting other biochemical markers such as sFlt-1, soluble endoglin, Papp-1, etc along with XX data from their patients would have strengthened their work. (這個reviewer提的指標我倒是能立馬補兩個ELISA的數(shù)據(jù),耗時不長。) 第一個reviewer的態(tài)度讓我比較迷惑,到底是讓我補實驗呢,還是……就是順嘴說了一句,也沒想讓我補實驗的? 以前讀書時寫文章都是老板寫了投了,告訴我有沒有接收,自己完全不知道怎么和編輯們打交道。 |
新蟲 (職業(yè)作家)
新蟲 (小有名氣)
木蟲 (著名寫手)
新蟲 (小有名氣)
至尊木蟲 (文壇精英)
金蟲 (著名寫手)

銀蟲 (小有名氣)

| 9 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考博] 26申博 求博導 +3 | 愛讀書的小帥 2026-02-28 | 5/250 |
|
|---|---|---|---|---|
|
[考研] 化工專碩調(diào)劑 +4 | 利好利好. 2026-03-03 | 7/350 |
|
|
[考研] 298求調(diào)劑 +3 | 人間唯你是清歡 2026-03-03 | 4/200 |
|
|
[碩博家園] 2025屆雙非化工碩士畢業(yè),申博 +4 | 更多的是 2026-02-27 | 5/250 |
|
|
[考研] 成績276,專業(yè)代碼0856求調(diào)劑 +7 | 小陳朵 2026-03-03 | 7/350 |
|
|
[考研]
|
glwshine 2026-03-02 | 5/250 |
|
|
[考研] 281電子信息求調(diào)劑 +3 | jhtfeybgj 2026-03-02 | 6/300 |
|
|
[考研] 沒上岸的看過來 +3 | tangxiaotian 2026-03-01 | 3/150 |
|
|
[考研]
材料325求調(diào)劑
30+3
|
mariusuki 2026-03-02 | 7/350 |
|
|
[考博] 26申博 +4 | north, 2026-02-28 | 4/200 |
|
|
[考研] 271求調(diào)劑 +4 | Ricardo1113 2026-03-02 | 4/200 |
|
|
[考研] 288求調(diào)劑 +3 | 少71.8 2026-03-02 | 5/250 |
|
|
[考研] 0856求調(diào)劑285 +11 | 呂仔龍 2026-02-28 | 11/550 |
|
|
[考研] 材料復試調(diào)劑 +5 | 學材料的點 2026-03-01 | 6/300 |
|
|
[考研] 306分材料調(diào)劑 +5 | chuanzhu川燭 2026-03-01 | 6/300 |
|
|
[考研] 261求調(diào)劑 +3 | 陸lh 2026-03-01 | 3/150 |
|
|
[考博] 博士自薦 +4 | kkluvs 2026-02-28 | 5/250 |
|
|
[基金申請] 此成果不能導入原因:元數(shù)據(jù)必填信息不完整,可 進行補充。 +4 | Kittylucky 2026-03-02 | 5/250 |
|
|
[考研] 322求調(diào)劑 +3 | 熊境喆 2026-03-01 | 3/150 |
|
|
[考研]
|
15779376950 2026-03-01 | 5/250 |
|